Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+

W H Hsu1, H D Xiang, A S Rajan

  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.

The Journal of Biological Chemistry
|January 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intersectionality and reflexivity-decolonizing methodologies for the data science process.

Patterns (New York, N.Y.)·2021
Same author

Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits.

Journal of veterinary pharmacology and therapeutics·2018
Same author

Development of a heat vulnerability index for New York State.

Public health·2017
Same author

Review of triazine antiprotozoal drugs used in veterinary medicine.

Journal of veterinary pharmacology and therapeutics·2017
Same author

Neural control of sweat secretion: a review.

The British journal of dermatology·2017
Same author

Impact of carprofen administration on stress and nociception responses of calves to cautery dehorning.

Journal of animal science·2016

Somatostatin (SRIF) inhibits insulin secretion by reducing calcium (Ca2+) influx via voltage-dependent channels in hamster beta cells. This action is mediated by a pertussis toxin-sensitive G-protein, impacting calcium levels and insulin release.

Area of Science:

  • Endocrinology
  • Cell Physiology
  • Molecular Pharmacology

Background:

  • Insulin secretion is tightly regulated by intracellular calcium levels.
  • Somatostatin (SRIF) is known to modulate various cellular functions, including hormone release.
  • The precise mechanisms by which SRIF influences insulin secretion require further elucidation, particularly regarding ion channel activity and signaling pathways.

Purpose of the Study:

  • To investigate the hypothesis that somatostatin inhibits insulin secretion by affecting voltage-dependent calcium channels in a hamster beta cell line (HIT cells).
  • To determine the involvement of G-proteins in the inhibitory action of somatostatin on insulin secretion.
  • To characterize the dose-dependent effects of somatostatin on calcium currents, intracellular calcium, and insulin release.

Main Methods:

Related Experiment Videos

  • Whole-cell patch-clamp electrophysiology to record calcium (Ca2+) currents.
  • Fura-2 fluorescence to monitor intracellular free calcium ([Ca2+]i).
  • Radioimmunoassay for measuring insulin secretion and cAMP levels.
  • Pertussis toxin treatment to assess G-protein involvement.

Main Results:

  • Somatostatin (SRIF) dose-dependently decreased Ca2+ currents, intracellular Ca2+ ([Ca2+]i), and basal insulin secretion.
  • SRIF attenuated K+-stimulated and Bay K 8644-induced increases in [Ca2+]i and insulin secretion.
  • Pertussis toxin pretreatment abolished SRIF's inhibitory effects, indicating G-protein mediation.

Conclusions:

  • Somatostatin inhibits insulin secretion by reducing calcium influx through voltage-dependent Ca2+ channels in HIT cells.
  • This inhibitory mechanism is mediated by a pertussis toxin-sensitive G-protein.
  • SRIF's action on calcium channels, not cAMP levels or K+ channels, is a key pathway for regulating insulin release.